产品名称
D-半胱氨酸, ≥99% (RT)
Quality Level
assay
≥99% (RT)
form
powder or crystals
optical activity
[α]20/D −7.6±1.0°, c = 5% in 5 M HCl
reaction suitability
reaction type: solution phase peptide synthesis
mp
~230 °C (dec.)
application(s)
peptide synthesis
SMILES string
N[C@H](CS)C(O)=O
InChI
1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m1/s1
InChI key
XUJNEKJLAYXESH-UWTATZPHSA-N
Application
半胱氨酸已用于QD的功能化,可应用于光催化作用。
也可用于以下物质的合成:
也可用于以下物质的合成:
- 基于半胱氨酸的手性碳点(CD)
- D-荧光素和氨基荧光素类似物
Packaging
无底玻璃瓶。内含物在插入的融合锥体内。
Other Notes
半胱氨酸的非天然异构体。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Antonia Asimakopoulou et al.
British journal of pharmacology, 169(4), 922-932 (2013-03-16)
Hydrogen sulfide (H₂S) is a signalling molecule that belongs to the gasotransmitter family. Two major sources for endogenous enzymatic production of H₂S are cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). In the present study, we examined the selectivity
Nar Singh Chauhan et al.
Indian journal of microbiology, 57(3), 299-306 (2017-09-15)
A metagenomic library of sea sediment metagenome containing 245,000 recombinant clones representing ~ 2.45 Gb of sea sediment microbial DNA was constructed. Two unique arsenic resistance clones, A7 and A12, were identified by selection on sodium arsenite containing medium. Clone A7 showed a
Angéla Takács et al.
Scientific reports, 10(1), 14287-14287 (2020-09-02)
Bortezomib (BOZ) is a proteasome inhibitor chemotherapeutic agent utilized to treat multiple myeloma and recently offered to cure melanoma. Bortezomib-induced neuropathy is one of the dose-limiting side-effects, which can be treated with antioxidants (e.g. alpha-lipoic acid-ALA and Vitamin B1-vit B1).
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 30095-100MG | 04061826660713 |
| 30095-1G | 04061826662182 |
